Finance

Lists
TECX:NASDAQ
Tectonic Therapeutic Inc
$21.14
+0.48%
(+0.100) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TECX...
Open
$20.96
High
$21.29
Low
$20.11
Mkt. cap
421.70M
Avg. vol.
184.92K
Volume
300.64K
52-wk high
$39.53
52-wk low
$16.77
EPS
-$4.63
Beta
1.30
Shares outstanding
19.95M
No. of employees
60
Open
$20.96
High
$21.29
Low
$20.11
Mkt. cap
421.70M
Avg. vol.
184.92K
Volume
300.64K
52-wk high
$39.53
52-wk low
$16.77
EPS
-$4.63
Beta
1.30
Shares outstanding
19.95M
No. of employees
60
News stories
From web sources and news partners
About Tectonic Therapeutic Inc
CEO-
Employees60
Founded2019
HeadquartersWatertown, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 7 analysts giving stock ratings to TECX in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for TECX in the last 3 months.
Highest
Current $21.14
$93.00 (+339.92%)
Average
$71.14 (+236.52%)
Lowest
$26.00 (+22.99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Oppenheimer
Buy
Maintained
$80.00
+278.4%
11/06/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
$75.00
+254.8%
11/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$76.00
+259.5%
11/06/2026
David Risinger
Leerink Partners
Buy
Reiterated
$60.00
+183.8%
10/15/2026
Unknown Analyst
UBS
Hold
Initiated
$26.00
+23%
10/11/2026
Alice Nettleton
UBS
Hold
Initiated
$26.00
+23%
10/11/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
$93.00
+339.9%
09/29/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
$88.00
+316.3%
09/29/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
$85.00
+302.1%
08/27/2026
Danielle Brill
Truist Financial
Buy
Maintained
$60.00
+183.8%
08/10/2026
Martin Auster
Raymond James
Buy
Maintained
$81.00
+283.2%
05/26/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
16.34M
20.87M
18.05M
17.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.18M
6.43M
6.17M
6.02M
Operating expense
21.52M
27.30M
24.22M
23.46M
Total operating expenses
21.52M
27.30M
24.22M
23.46M
Operating income
-21.52M
-27.30M
-24.22M
-23.46M
Other non operating income
-8.00K
-113.00K
-5.00K
-1.00K
EBT including unusual items
-18.97M
-25.24M
-22.21M
-21.35M
EBT excluding unusual items
-18.97M
-25.24M
-22.21M
-21.35M
Income tax expense
254.00K
-
77.00K
-
Effective tax rate
-1.34%
-
-0.35%
-
Other operating expenses
-
-
-
-
Net income
-19.23M
-25.24M
-22.28M
-21.35M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-1.08
Interest and investment income
2.56M
2.18M
2.02M
2.12M
Interest expense
-12.00K
-8.00K
-6.00K
-4.00K
Net interest expenses
2.55M
2.17M
2.02M
2.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.18M
-27.00M
-23.93M
-23.21M
Gain or loss from assets sale
-
23.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps